{"disease":{"id":"retina","name":"retina"},"drugs":{"marketed":[{"drug_id":"aflibercept","indication_name":"Central retinal vein occlusion with macular edema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vegf Trap","generic_name":"AFLIBERCEPT","company_name":"Regeneron","drug_phase":"marketed","molecular_target":"Vascular endothelial growth factor A","drug_class":"Vascular Endothelial Growth Factor Inhibitor","quality_score":55,"revenue":"9800","mechanism":""},{"drug_id":"aflibercept","indication_name":"Branch retinal vein occlusion with macular edema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vegf Trap","generic_name":"AFLIBERCEPT","company_name":"Regeneron","drug_phase":"marketed","molecular_target":"Vascular endothelial growth factor A","drug_class":"Vascular Endothelial Growth Factor Inhibitor","quality_score":55,"revenue":"9800","mechanism":""},{"drug_id":"dexamethasone","indication_name":"Branch retinal vein occlusion with macular edema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Decadron","generic_name":"dexamethasone","company_name":"Generic (originally Merck)","drug_phase":"marketed","molecular_target":"Annexin A1, Interleukin-4, Androgen receptor","drug_class":"Corticosteroid [EPC]","quality_score":44,"revenue":null,"mechanism":""},{"drug_id":"dexamethasone","indication_name":"Central retinal vein occlusion with macular edema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Decadron","generic_name":"dexamethasone","company_name":"Generic (originally Merck)","drug_phase":"marketed","molecular_target":"Annexin A1, Interleukin-4, Androgen receptor","drug_class":"Corticosteroid [EPC]","quality_score":44,"revenue":null,"mechanism":""},{"drug_id":"visudyne","indication_name":"Choroidal retinal neovascularization","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Visudyne","company_name":"Bayer","drug_phase":"discontinued","molecular_target":"","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"eylea","indication_name":"Branch retinal vein occlusion with macular edema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Eylea","company_name":"Texas Retina Associates","drug_phase":"marketed","molecular_target":"Placenta growth factor, Vascular endothelial growth factor A, Vascular endothelial growth factor B","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"eylea","indication_name":"Central retinal vein occlusion with macular edema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Eylea","company_name":"Texas Retina Associates","drug_phase":"marketed","molecular_target":"Placenta growth factor, Vascular endothelial growth factor A, Vascular endothelial growth factor B","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"lucentis","indication_name":"Branch retinal vein occlusion with macular edema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Lucentis","company_name":"Santen Inc.","drug_phase":"marketed","molecular_target":"Vascular endothelial growth factor A","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"lucentis","indication_name":"Central retinal vein occlusion with macular edema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Lucentis","company_name":"Santen Inc.","drug_phase":"marketed","molecular_target":"Vascular endothelial growth factor A","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"lucentis","indication_name":"Choroidal retinal neovascularization","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Lucentis","company_name":"Santen Inc.","drug_phase":"marketed","molecular_target":"Vascular endothelial growth factor A","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"ranibizumab-nuna","indication_name":"Branch retinal vein occlusion with macular edema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"BYOOVIZ","generic_name":"RANIBIZUMAB-NUNA","company_name":"SAMSUNG BIOEPIS CO LTD","drug_phase":"marketed","molecular_target":"Vascular endothelial growth factor A","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"ranibizumab-nuna","indication_name":"Central retinal vein occlusion with macular edema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"BYOOVIZ","generic_name":"RANIBIZUMAB-NUNA","company_name":"SAMSUNG BIOEPIS CO LTD","drug_phase":"marketed","molecular_target":"Vascular endothelial growth factor A","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"ranibizumab-eqrn","indication_name":"Macular Edema Following Retinal Vein Occlusion (RVO)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"CIMERLI","generic_name":"RANIBIZUMAB-EQRN","company_name":"SANDOZ INC","drug_phase":"marketed","molecular_target":"","drug_class":"Vascular Endothelial Growth Factor Inhibitor [EPC]","quality_score":18,"revenue":null,"mechanism":""},{"drug_id":"ranibizumab-nuna","indication_name":"Choroidal retinal neovascularization","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"BYOOVIZ","generic_name":"RANIBIZUMAB-NUNA","company_name":"SAMSUNG BIOEPIS CO LTD","drug_phase":"marketed","molecular_target":"Vascular endothelial growth factor A","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"verteporfin","indication_name":"Choroidal retinal neovascularization","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Visudyne","generic_name":"VERTEPORFIN","company_name":"Bausch Lomb Ireland","drug_phase":"marketed","molecular_target":"","drug_class":"Photoenhancer [EPC]","quality_score":10,"revenue":null,"mechanism":"Visudyne selectively binds to neovascular tissue, which is then activated by light to induce a phototoxic reaction."}],"pipeline":[],"offLabel":[],"totalMarketed":15,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04678375","title":"Artificial Intelligence for Detecting Retinal Diseases","phase":"","overall_status":"COMPLETED","enrollment_count":1000000,"lead_sponsor_name":"Beijing Tongren Hospital","has_results":false},{"nct_id":"NCT06769412","title":"A Real-World Evidence Study for the Incidence of Retinal Vasculitis (RV) Among Adult Patients Receiving Aflibercept 2 mg in the United States (US)","phase":"","overall_status":"COMPLETED","enrollment_count":550000,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":false},{"nct_id":"NCT07105228","title":"Incidence of Retinal Vasculitis Among Patients Receiving Aflibercept: A US Real-World Evidence Study","phase":"","overall_status":"COMPLETED","enrollment_count":290000,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":false},{"nct_id":"NCT03479736","title":"A Study of Fluoroquinolones Exposure and Collagen-Related Serious Adverse Events","phase":"","overall_status":"COMPLETED","enrollment_count":117911,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":false},{"nct_id":"NCT05981950","title":"Real-world of AI in Diagnosing Retinal Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":100000,"lead_sponsor_name":"Beijing Tongren Hospital","has_results":false},{"nct_id":"NCT06287645","title":"Color Fundus Photograph With Experts Labelling","phase":"","overall_status":"RECRUITING","enrollment_count":50000,"lead_sponsor_name":"Pakistan Council of Scientific and Industrial Research","has_results":false},{"nct_id":"NCT07308639","title":"DATA-INSIGHT is a Project That Looks at Health Data in Germany to Find Out How Many Patients Suffer From Eye Disease. The Project Also Explores New Ways to Collect and Use Publicly Available Healthcare Information.","phase":"","overall_status":"RECRUITING","enrollment_count":50000,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT07482228","title":"Long-term Clinical Outcomes After Retinal Artery Occlusion","phase":"","overall_status":"RECRUITING","enrollment_count":15000,"lead_sponsor_name":"Chonnam National University Hospital","has_results":false},{"nct_id":"NCT04592068","title":"AI Classifies Multi-Retinal Diseases","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"Beijing Tongren Hospital","has_results":false},{"nct_id":"NCT04935749","title":"Epidemiologic Assessment of Diabetic Retinopathy in Egypt Using Ultrawide Field Fundus Photographs","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"Alexandria University","has_results":false},{"nct_id":"NCT05476926","title":"A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":6000,"lead_sponsor_name":"Hoffmann-La Roche","has_results":false},{"nct_id":"NCT03753893","title":"Ocular Manifestations in Rheumatic Diseases","phase":"","overall_status":"COMPLETED","enrollment_count":5000,"lead_sponsor_name":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","has_results":false},{"nct_id":"NCT07143851","title":"Multi-modal Intelligent Diagnosis System for Multiple Ophthalmic Diseases","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Beijing Hospital","has_results":false},{"nct_id":"NCT00001310","title":"Tissue Studies of Human Eye Diseases","phase":"","overall_status":"TERMINATED","enrollment_count":3833,"lead_sponsor_name":"National Eye Institute (NEI)","has_results":false},{"nct_id":"NCT00231010","title":"Molecular Genetics of Retinal Degenerations","phase":"","overall_status":"COMPLETED","enrollment_count":3549,"lead_sponsor_name":"National Eye Institute (NEI)","has_results":false},{"nct_id":"NCT06123923","title":"Trends of Vitreoretinal Surgery in Children","phase":"","overall_status":"COMPLETED","enrollment_count":3509,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT06431711","title":"Fundus Optical coheRence Tomography Angiography Evaluation for Small-vessel Health in Cerebral Small Vessel Disease","phase":"","overall_status":"RECRUITING","enrollment_count":2400,"lead_sponsor_name":"Zhejiang Provincial People's Hospital","has_results":false},{"nct_id":"NCT07249307","title":"High-throughput Large-model-based AI-assisted Diagnosis Using OCT","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT00001733","title":"Screening for Studies on Retinovascular Diseases","phase":"","overall_status":"COMPLETED","enrollment_count":2000,"lead_sponsor_name":"National Eye Institute (NEI)","has_results":false},{"nct_id":"NCT04718532","title":"A New Technique For Retinal Disease Treatment","phase":"","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT06213896","title":"Detecting Eye Diseases Via Hybrid Deep Learning Algorithms From Fundus Images","phase":"","overall_status":"COMPLETED","enrollment_count":1528,"lead_sponsor_name":"Ural Telekomunikasyon Sanayi Ticaret Anonim Sirketi","has_results":false},{"nct_id":"NCT05589714","title":"Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants","phase":"","overall_status":"RECRUITING","enrollment_count":1500,"lead_sponsor_name":"Jaeb Center for Health Research","has_results":false},{"nct_id":"NCT05576285","title":"Retinal Imaging Study of Children That Might be at Risk of Having Retinal Hemorrhages","phase":"","overall_status":"UNKNOWN","enrollment_count":1500,"lead_sponsor_name":"Region Stockholm","has_results":false},{"nct_id":"NCT06495203","title":"A Study to Understand the Usage of an Artificial Intelligence Technology Called DARWEN for Eye Disorders and to Find Out the Factors Influencing Treatment Frequencies in People With nAMD and RVO","phase":"","overall_status":"COMPLETED","enrollment_count":1350,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT04666103","title":"Function Integrity of Neck Anatomy in Thyroid Surgery","phase":"NA","overall_status":"RECRUITING","enrollment_count":1264,"lead_sponsor_name":"Wuhan University","has_results":false},{"nct_id":"NCT04620876","title":"Bimodal and Coaxial High Resolution Ophtalmic Imaging","phase":"NA","overall_status":"UNKNOWN","enrollment_count":1200,"lead_sponsor_name":"Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts","has_results":false},{"nct_id":"NCT04056377","title":"Exercise, Arterial Modulation and Nutrition in Youth South Africa Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1065,"lead_sponsor_name":"North-West University, South Africa","has_results":false},{"nct_id":"NCT04505618","title":"Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease","phase":"NA","overall_status":"RECRUITING","enrollment_count":1050,"lead_sponsor_name":"Johns Hopkins University","has_results":false},{"nct_id":"NCT04128150","title":"High Resolution Retina Imaging","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts","has_results":false},{"nct_id":"NCT06439576","title":"Real World Evidence in China: Faricimab Use in Diabetic Macular Edema, Retinal Vein Occlusion, and Neovascular Age-Related Macular Degeneration (The Farseeing Study)","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Hoffmann-La Roche","has_results":false},{"nct_id":"NCT06757595","title":"Retrospective Analysis of the Clinical Characteristics of Retinal Vein Occlusion","phase":"","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"Zhongnan Hospital","has_results":false},{"nct_id":"NCT00005784","title":"Evaluation and Treatment of Patients With Retinal Disease","phase":"","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"National Eye Institute (NEI)","has_results":false},{"nct_id":"NCT04131400","title":"Establishment of the National Registry for Inherited Retinal Dystrophy in Iran","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Shahid Beheshti University of Medical Sciences","has_results":false},{"nct_id":"NCT05222633","title":"Anti-VEGF in Real-world","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Wenbin Wei","has_results":false},{"nct_id":"NCT05122442","title":"Multicenter, Non-interventional Study, Describing Patients With Inherited Retinal Disease (IRD) in France","phase":"","overall_status":"COMPLETED","enrollment_count":998,"lead_sponsor_name":"University Hospital, Strasbourg, France","has_results":true},{"nct_id":"NCT01432847","title":"Cell Collection to Study Eye Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":930,"lead_sponsor_name":"National Eye Institute (NEI)","has_results":false},{"nct_id":"NCT05850520","title":"A Study to Learn How Well a Higher Amount of Aflibercept Given as an Injection Into the Eye Works and How Safe it is in People With Reduced Vision Due to Swelling in the Macula, Central Part of the Retina Caused by a Blocked Vein in the Retina (Macula Edema Secondary to Retinal Vein Occlusion)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":892,"lead_sponsor_name":"Bayer","has_results":true},{"nct_id":"NCT05957276","title":"Global Patient Registry of Inherited Retinal Diseases","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":889,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":false},{"nct_id":"NCT03538847","title":"Postoperative Pain After Vitreoretinal Surgery","phase":"","overall_status":"COMPLETED","enrollment_count":800,"lead_sponsor_name":"University of Florence","has_results":false},{"nct_id":"NCT05836194","title":"Evaluation of Diabetic Retinopathy Using Ultra-Widefield Fundus Images Compared With Two-Field Fundus Images","phase":"","overall_status":"COMPLETED","enrollment_count":769,"lead_sponsor_name":"Ningbo Eye Hospital","has_results":false},{"nct_id":"NCT04723160","title":"Computer Aided Diagnosis of Multiple Eye Fundus Diseases From Color Fundus Photograph","phase":"","overall_status":"COMPLETED","enrollment_count":748,"lead_sponsor_name":"Visionary Intelligence Ltd.","has_results":false},{"nct_id":"NCT03863548","title":"French Observational Study of Complications Associated With Anticoagulants and Antiplatelet Treatment in Retina/Vitreous Surgery","phase":"","overall_status":"COMPLETED","enrollment_count":748,"lead_sponsor_name":"Centre Hospitalier Universitaire Dijon","has_results":false},{"nct_id":"NCT04740931","title":"A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":729,"lead_sponsor_name":"Hoffmann-La Roche","has_results":true},{"nct_id":"NCT06390579","title":"Building Research With Artificial Intelligence in Neuro-Ophthalmology","phase":"","overall_status":"COMPLETED","enrollment_count":693,"lead_sponsor_name":"Fondation Ophtalmologique Adolphe de Rothschild","has_results":false},{"nct_id":"NCT07530783","title":"Defining Retinal and Choroidal Structures Using Hyperspectral Imaging","phase":"NA","overall_status":"TERMINATED","enrollment_count":679,"lead_sponsor_name":"Center for Eye Research Australia","has_results":false},{"nct_id":"NCT00168298","title":"A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":668,"lead_sponsor_name":"Allergan","has_results":true},{"nct_id":"NCT03065881","title":"RETeval All Comers Trial (REACT)","phase":"NA","overall_status":"COMPLETED","enrollment_count":664,"lead_sponsor_name":"LKC Technologies, Inc.","has_results":false},{"nct_id":"NCT01496625","title":"National Eye Institute Biorepository for Retinal Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":650,"lead_sponsor_name":"National Eye Institute (NEI)","has_results":false},{"nct_id":"NCT05158699","title":"Effectiveness of Periocular Drug Injection in CATaract Surgery","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":628,"lead_sponsor_name":"Luigi Rondas","has_results":false},{"nct_id":"NCT05287269","title":"Ocular Coherence Tomography During Cataract Assessment","phase":"","overall_status":"COMPLETED","enrollment_count":626,"lead_sponsor_name":"Brighton and Sussex University Hospitals NHS Trust","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}